Literature DB >> 23383120

Postprandial changes in high density lipoproteins in rats subjected to gavage administration of virgin olive oil.

Roberto Martínez-Beamonte1, María A Navarro, Sergio Acin, Natalia Guillén, Cristina Barranquero, Carmen Arnal, Joaquín Surra, Jesus Osada.   

Abstract

BACKGROUND AND AIMS: The present study was designed to verify the influence of acute fat loading on high density lipoprotein (HDL) composition, and the involvement of liver and different segments of small intestine in the changes observed. METHODS AND
RESULTS: To address these issues, rats were administered a bolus of 5-ml of extra-virgin olive oil and sacrificed 4 and 8 hours after feeding. In these animals, lipoproteins were analyzed and gene expressions of apolipoprotein and HDL enzymes were assessed in duodenum, jejunum, ileum and liver. Using this experimental design, total plasma and HDL phospholipids increased at the 8-hour-time-point due to increased sphingomyelin content. An increase in apolipoprotein A4 was also observed mainly in lipid-poor HDL. Increased expression of intestinal Apoa1, Apoa4 and Sgms1 mRNA was accompanied by hepatic decreases in the first two genes in liver. Hepatic expression of Abcg1, Apoa1bp, Apoa2, Apoe, Ptlp, Pon1 and Scarb1 decreased significantly following fat gavage, while no changes were observed for Abca1, Lcat or Pla2g7. Significant associations were also noted for hepatic expression of apolipoproteins and Pon1. Manipulation of postprandial triglycerides using an inhibitor of microsomal transfer protein -CP-346086- or of lipoprotein lipase -tyloxapol- did not influence hepatic expression of Apoa1 or Apoa4 mRNA.
CONCLUSION: All these data indicate that dietary fat modifies the phospholipid composition of rat HDL, suggesting a mechanism of down-regulation of hepatic HDL when intestine is the main source of those particles and a coordinated regulation of hepatic components of these lipoproteins at the mRNA level, independently of plasma postprandial triglycerides.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23383120      PMCID: PMC3558467          DOI: 10.1371/journal.pone.0055231

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  66 in total

Review 1.  Chylomicrons in disease-future challenges Invited keynote address.

Authors:  Trevor G Redgrave
Journal:  Atheroscler Suppl       Date:  2008-06-27       Impact factor: 3.235

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Apolipoprotein A-IV synthesis in proximal jejunum is stimulated by ileal lipid infusion.

Authors:  T J Kalogeris; T Tsuchiya; K Fukagawa; R Wolf; P Tso
Journal:  Am J Physiol       Date:  1996-02

4.  Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes.

Authors:  P H Weinstock; C L Bisgaier; K Aalto-Setälä; H Radner; R Ramakrishnan; S Levak-Frank; A D Essenburg; R Zechner; J L Breslow
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

Review 5.  HDL-related mechanisms of olive oil protection in cardiovascular disease.

Authors:  José M Lou-Bonafonte; Montse Fitó; María-Isabel Covas; Marta Farràs; Jesús Osada
Journal:  Curr Vasc Pharmacol       Date:  2012-07       Impact factor: 2.719

6.  Apolipoprotein A-IV attenuates oxidant-induced apoptosis in mitotic competent, undifferentiated cells by modulating intracellular glutathione redox balance.

Authors:  Heather L Spaulding; Fumito Saijo; Richard H Turnage; J Steven Alexander; Tak Yee Aw; Theodore J Kalogeris
Journal:  Am J Physiol Cell Physiol       Date:  2005-08-24       Impact factor: 4.249

Review 7.  Control of synthesis and secretion of intestinal apolipoprotein A-IV by lipid.

Authors:  T J Kalogeris; M D Rodriguez; P Tso
Journal:  J Nutr       Date:  1997-03       Impact factor: 4.798

8.  Sphingomyelin synthase 2 is one of the determinants for plasma and liver sphingomyelin levels in mice.

Authors:  Jing Liu; Hongqi Zhang; Zhiqiang Li; Tiruneh K Hailemariam; Mahua Chakraborty; Kailiu Jiang; Daniel Qiu; Hai H Bui; David A Peake; Ming-Shang Kuo; Raj Wadgaonkar; Guoqing Cao; Xian-Cheng Jiang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-03-12       Impact factor: 8.311

9.  Knockout rats via embryo microinjection of zinc-finger nucleases.

Authors:  Aron M Geurts; Gregory J Cost; Yevgeniy Freyvert; Bryan Zeitler; Jeffrey C Miller; Vivian M Choi; Shirin S Jenkins; Adam Wood; Xiaoxia Cui; Xiangdong Meng; Anna Vincent; Stephen Lam; Mieczyslaw Michalkiewicz; Rebecca Schilling; Jamie Foeckler; Shawn Kalloway; Hartmut Weiler; Séverine Ménoret; Ignacio Anegon; Gregory D Davis; Lei Zhang; Edward J Rebar; Philip D Gregory; Fyodor D Urnov; Howard J Jacob; Roland Buelow
Journal:  Science       Date:  2009-07-24       Impact factor: 47.728

Review 10.  Intestinally derived lipids: metabolic regulation and consequences--an overview.

Authors:  Katherine Cianflone; Sabina Paglialunga; Christian Roy
Journal:  Atheroscler Suppl       Date:  2008-08-06       Impact factor: 3.235

View more
  9 in total

1.  Diet-induced hypercholesterolemia alters liver glycosaminoglycans and associated-lipoprotein receptors in rats.

Authors:  Gangappa Kiran; Ummiti J S Prasada Rao; Paramahans V Salimath; Nandini D Chilkunda
Journal:  J Physiol Biochem       Date:  2017-07-31       Impact factor: 4.158

2.  Dietary squalene increases high density lipoprotein-cholesterol and paraoxonase 1 and decreases oxidative stress in mice.

Authors:  Clara Gabás-Rivera; Cristina Barranquero; Roberto Martínez-Beamonte; María A Navarro; Joaquín C Surra; Jesús Osada
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

3.  Effect of virgin olive oil versus piroxicam phonophoresis on exercise-induced anterior knee pain.

Authors:  Babak Nakhostin-Roohi; Faegheh Khoshkhahesh; Shahab Bohlooli
Journal:  Avicenna J Phytomed       Date:  2016 Sep-Oct

Review 4.  Is Extra Virgin Olive Oil an Ally for Women's and Men's Cardiovascular Health?

Authors:  Flavia Franconi; Ilaria Campesi; Annalisa Romani
Journal:  Cardiovasc Ther       Date:  2020-04-24       Impact factor: 3.023

5.  Dietary Avian Proteins Are Comparable to Soybean Proteins on the Atherosclerosis Development and Fatty Liver Disease in Apoe-Deficient Mice.

Authors:  Roberto Martínez-Beamonte; Javier Sánchez-Marco; Gonzalo Lázaro; María Barco; Tania Herrero-Continente; Marta Serrano-Megías; David Botaya; Carmen Arnal; Cristina Barranquero; Joaquín C Surra; Jesús Osada; María A Navarro
Journal:  Nutrients       Date:  2021-05-27       Impact factor: 5.717

Review 6.  Sphingomyelin in high-density lipoproteins: structural role and biological function.

Authors:  Roberto Martínez-Beamonte; Jose M Lou-Bonafonte; María V Martínez-Gracia; Jesús Osada
Journal:  Int J Mol Sci       Date:  2013-04-09       Impact factor: 5.923

Review 7.  Effects of Virgin Olive Oil and Phenol-Enriched Virgin Olive Oils on Lipoprotein Atherogenicity.

Authors:  Marta Farràs; Marina Canyelles; Montserrat Fitó; Joan Carles Escolà-Gil
Journal:  Nutrients       Date:  2020-02-26       Impact factor: 5.717

8.  Thioredoxin Domain Containing 5 Suppression Elicits Serum Amyloid A-Containing High-Density Lipoproteins.

Authors:  Javier Sánchez-Marco; Roberto Martínez-Beamonte; Alicia De Diego; Tania Herrero-Continente; Cristina Barranquero; Carmen Arnal; Joaquín Surra; María A Navarro; Jesús Osada
Journal:  Biomedicines       Date:  2022-03-18

9.  Crosstalk of low density lipoprotein and liposome as a paradigm for targeting of 5-fluorouracil into hepatic cells: cytotoxicity and liver deposition.

Authors:  Saleh A Alanazi; Gamaleldin I Harisa; Mohamed M Badran; Fars K Alanazi; Ehab Elzayat; Abdullah H Alomrani; Osaid T Al Meanazel; Ahmed T Al Meanazel
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.